Insulatard Flexpen

Insulin human, the active ingredient in Insulatard Flexpen, is an intermediate‑acting insulin presented as an injectable solution (pen) for subcutaneous use. It is used to lower elevated blood glucose in patients with type 1 diabetes mellitus and type 2 diabetes mellitus, providing basal insulin coverage.

GNH USA supplies Insulatard Flexpen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides cold‑chain logistics to ensure product integrity during transport. Customers receive full regulatory documentation and batch traceability.

Insulatard Flexpen, an intermediate‑acting insulin, is employed in the management of diabetes mellitus and related hyperglycaemic conditions.

- Type 1 diabetes mellitus: provides basal insulin to maintain fasting glucose levels. - Type 2 diabetes mellitus: complements oral agents to achieve overall glycaemic control. - Insulin‑deficient hyperglycaemia: stabilises blood glucose when endogenous insulin production is insufficient.

Common Side Effects: - Hypoglycaemia: low blood glucose episodes, especially if meals are missed or activity increases. - Injection site pain or erythema: mild discomfort at the subcutaneous injection site. - Weight gain: gradual increase due to improved glucose utilisation. - Lipodystrophy: localized fat tissue changes with repeated injections.

Serious or Rare Side Effects: - Severe hypoglycaemia: profound low glucose requiring assistance. - Allergic reaction including anaphylaxis: rash, swelling, respiratory distress. - Insulin antibody formation: may alter insulin effectiveness and cause unpredictable glucose levels.

When using Insulatard Flexpen, consider the following precautions.

- Dose individualisation: Adjust based on blood‑glucose monitoring and clinical response. - Hypoglycaemia risk: Educate patients to recognise and treat low blood sugar promptly. - Renal impairment: Use with caution; monitor glucose closely. - Pregnancy and lactation: Use only if benefits outweigh potential risks. - Drug interactions: Review concomitant medications that affect glucose homeostasis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulatard Flexpen may interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Concurrent sulfonylureas: increased risk of hypoglycaemia. - Beta‑blockers: may mask typical hypoglycaemia symptoms. - Systemic corticosteroids: may necessitate higher insulin doses.

Moderate Interactions (Monitor Closely): - ACE inhibitors: can enhance insulin sensitivity, potentially lowering glucose. - Thiazide diuretics: may raise blood glucose levels. - Oral contraceptives: may affect insulin requirements.